~~<i id='0689EC4549'><strike id='0689EC4549'><tt id='0689EC4549'><pre id='0689EC4549'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

entertainment

author：entertainment 2025-09-29 22:48:25 - browse：1618

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： H5N1 bird flu found in pasteurized milk: what we know

focus

explore

leisure time

Wikipedia

focus

DarronCummings/APEliLillysaidTuesdaythatitwillpurchaseDICETherapeutics,asmallcompanydevelopinganexpe

WSS

Why does health care cost so much? A reading guide

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

In rare move, senator releases unverified FBI source report alleging Biden bribe

Melinda French Gates resigns from Gates Foundation

Why rehabilitation engineers need to center patients in their research

Judge denies Trump's request for new trial in E. Jean Carroll case

explore

entertainment

focus

Psychedelics group wrestles with new pharma identity

Sanders wants to replace patents with prizes for drug inventions

In age of alternative facts, a scholarly course on calling out crap

Cancer researcher Catriona Jamieson is sending tumors into space

Apple is now the first public company to be valued at $3 trillion

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Cancer drug shortages should be causing more outrage

Extensive review finds private equity owners jack up cost of care

Guidelines to prevent youth baseball injuries need more muscle

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

explore

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Element Biosciences CEO lays out genome sequencing strategy

Sanders wants to replace patents with prizes for drug inventions

H5N1 bird flu virus started spreading in cows in Texas in December

Judge denies Trump's request for new trial in E. Jean Carroll case

Medical bills so high, Medicare adding extra digits to claim forms

leisure time

leisure time

Wikipedia

focus